New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
10:47 EDTMYGNMyriad Genetics to participate in hereditary cancer research collaboration
Myriad Genetics said it will team up with cancer experts from the Memorial Sloan Kettering Cancer Center (MSKCC), Mayo Clinic, Abramson Cancer Center of the University of Pennsylvania and other laboratories in a new partnership to advance the understanding of the risks associated with multiple cancer genes. Specifically, the partners will collaborate on the creation of a research study called the Prospective Registry of Multiplex Testing, or PROMPT, to which Myriad will contribute thousands of genetic mutations and its scientific expertise gained from having tested over 1.3M patients for hereditary cancer risk.
News For MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
10:21 EDTMYGNMyriad denied appeal to block competing breast cancer tests, Bloombeg reports
Subscribe for More Information
December 11, 2014
12:54 EDTMYGNMyriad Genetics management to meet with William Blair
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use